Swipe om te navigeren naar een ander artikel
To characterize quality of life (QOL) using real-time, electronic patient-reported outcomes (ePROs) and to evaluate adverse events (AEs) and supportive care during head-and-neck radiotherapy (RT) and concurrent chemoradiotherapy (CCRT).
Sixty-five patients undergoing head-and-neck RT completed electronic, real-time, 12-item linear analog self-assessments (LASA) at baseline, before biweekly appointments, and at the last week of RT. Changes in QOL domains between time points were calculated. Clinical data were collected from the institutional medical record. AEs were recorded at the same time points as the LASA and graded.
During head-and-neck RT, most patients had clinically meaningful decreases in all QOL domains except level of support, financial concerns, and legal concerns. QOL domains with the most prevalent, clinically meaningful decreases were fatigue (75.4% of patients; 95% CI, 62.9–84.9%), social activity (70.8%; 95% CI, 58.0–81.1%), and overall QOL (70.8%; 95% CI, 58.0–81.1%). All patients had grade 2 AEs; 35.4% had grade 3 (50.0%, CCRT; 12.0%, RT; P = .002). Weight loss averaged 5.5 kg (6.9 kg, CCRT; 2.8 kg, RT; P < .001). Intravenous hydration was needed in 52.3% (77.5%, CCRT; 12.0%, RT; P < .001); feeding tube placement 40.0% (57.5%, CCRT; 12.0%, RT; P = .001); emergency department visits without hospitalization, 10.8%; and emergent hospitalization, 27.7% (37.5%, CCRT; 12.0%, RT; P = .04).
Head-and-neck RT, particularly CCRT, negatively impacts patients’ overall QOL, social activity, and fatigue, with frequent grade 3 AEs, weight loss, intravenous hydration, feeding tube placement, ED visits, and hospitalization. Real-time ePROs allow providers to monitor QOL at multiple time points during RT, potentially allowing early intervention to improve QOL and mitigate AEs.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Rosenthal, D. I., Mendoza, T. R., Fuller, C. D., Hutcheson, K. A., Wang, X. S., Hanna, E. Y., et al. (2014). Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer, 120(13), 1975–1984. CrossRefPubMedPubMedCentral
Hubbard, J. M., Grothey, A. F., McWilliams, R. R., Buckner, J. C., & Sloan, J. A. (2014)Physician perspective on incorporation of oncology patient quality-of-life, fatigue, and pain assessment into clinical practice. Journal of Oncology Practice, 10(4):248–253.
Detmar, S. B., & Aaronson, N. K. (1998). Quality of life assessment in daily clinical oncology practice: A feasibility study. European Journal of Cancer (Oxford, England: 1990), 34(8), 1181–1186. CrossRef
Passik, S. D., Dugan, W., McDonald, M. V., Rosenfeld, B., Theobald, D. E., & Edgerton, S. (1998). Oncologists’ recognition of depression in their patients with cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 16(4), 1594–1600. CrossRef
Siddiqui, F., Pajak, T. F., Watkins-Bruner, D., Konski, A. A., Coyne, J. C., Gwede, C. K., et al. (2008). Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. International Journal of Radiation Oncology Biology Physics, 70(2), 353–360. CrossRef
Grignon, L. M., Jameson, M. J., Karnell, L. H., Christensen, A. J., & Funk, G. F. (2007). General health measures and long-term survival in patients with head and neck cancer. Archives of Otolaryngology—Head & Neck Surgery, 133(5), 471–476. CrossRef
Yang, C. J., Roh, J. L., Kim, M. J., Lee, S. W., Kim, S. B., Choi, S. H., et al. (2016 Jan). Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer. Quality of Life Research: An International Journal of Quality of Life aspects of Treatment, Care and Rehabilitation, 25(1), 165–174. CrossRef
Rathod, S., Gupta, T., Ghosh-Laskar, S., Murthy, V., Budrukkar, A., & Agarwal, J. (2013). Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study. Oral oncology, 49(6), 634–642. CrossRefPubMed
Pow, E. H., Kwong, D. L., McMillan, A. S., Wong, M. C., Sham, J. S., Leung, L. H., et al. (2006). Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial. International Journal of Radiation Oncology Biology Physics, 66(4), 981–991. CrossRef
Kam, M. K., Leung, S. F., Zee, B., Chau, R. M., Suen, J. J., Mo, F., et al. (2007). Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 25(31), 4873–4879. CrossRef
Nutting, C. M., Morden, J. P., Harrington, K. J., Urbano, T. G., Bhide, S. A., Clark, C., et al.; PARSPORT trial management group (2011). Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial. The Lancet Oncology, 12(2), 127–136. CrossRefPubMedPubMedCentral
Leung, S.W., Lee, T. F., Chien, C. Y., Chao, P. J., Tsai, W. L., & Fang, F. M. (2011). Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires. BMC cancer, 11, 128. CrossRef
Fang, F. M., Chien, C. Y., Tsai, W. L., Chen, H. C., Hsu, H. C., Lui, C. C., et al. (2008). Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy: A longitudinal study. International Journal of Radiation Oncology Biology, 72(2), 356–364. CrossRef
Vergeer, M. R., Doornaert, P. A., Rietveld, D. H., Leemans, C. R., Slotman, B. J., & Langendijk, J. A. (2009). Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. International Journal of Radiation Oncology Biology, 74(1), 1–8. CrossRef
Murphy, B. A., Gilbert, J., Cmelak, A., & Ridner, S. H. (2007). Symptom control issues and supportive care of patients with head and neck cancers. Clinical Advances in Hematology & Oncology: H&O, 5(10), 807–822.
Snyder, C. F., Blackford, A. L., Wolff, A. C., Carducci, M. A., Herman, J. M., & Wu, A. W.; Patient Viewpoint Scientific Advisory Board (2013). Feasibility and value of PatientViewpoint: A web system for patient-reported outcomes assessment in clinical practice. Psycho-oncology, 22(4), 895–901. CrossRefPubMed
Halyard, M. Y., Tan, A., Callister, M. D., Ashman, J. B., Vora, S. A., Wong, W., et al. (2010). Assessing the clinical significance of real-time quality of life (QOL) data in cancer patients treated with radiation therapy. Journal of Clinical Oncology, 28(15s), 9107. CrossRef
Grunberg, S. M., Groshen, S., Steingass, S., Zaretsky, S., & Meyerowitz, B. (1996). Comparison of conditional quality of life terminology and visual analogue scale measurements. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 5(1), 65–72. CrossRef
Gudex, C., Dolan, P., Kind, P., & Williams, A. (1996). Health state valuations from the general public using the visual analogue scale. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 5(6), 521–531. CrossRef
Hyland, M. E., & Sodergren, S. C. (1996). Development of a new type of global quality of life scale, and comparison of performance and preference for 12 global scales. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 5(5), 469–480. CrossRef
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2004). The truly remarkable universality of half a standard deviation: Confirmation through another look. Expert Review of Pharmacoeconomics & Outcomes Research, 4(5), 581–585. CrossRef
US Department of Health and Human Services, National Institutes of Health, National Cancer Institute [Internet]. Common terminology criteria for adverse events (CTCAE). Version 4.0; 2009 May 28. Retrieved Jun 14, from: http://www.hrc.govt.nz/sites/default/files/CTCAE%20manual%20-%20DMCC.pdf.
Farrell, P. J., Salibian-Barrera, M., & Naczk, K. (2007). On tests for multivariate normality and associated simulation studies. Journal of Statistical Computatio Simulation, 77(12), 1065–1080. CrossRef
Blair, R. C., & Higgins, J. J. (1980). A comparison of the power of Wilcoxon’s rank-sum statistic to that of student’s t statistic under various nonnormal distributions. Journal of Educational Statistics, 5(4), 309–335. CrossRef
Sloan, J. (2002). Asking the obvious questions regarding patient burden. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 20(1), 4–6. CrossRef
Sloan, J. A., Zhao, X., Novotny, P. J., Wampfler, J., Garces, Y., Clark, M. M., et al. (2012). Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. Jornal of Clinical Oncology, 30(13), 1498–1504. CrossRef
Curran, D., Giralt, J., Harari, P. M., Ang, K. K., Cohen, R. B., Kies, M. S., et al. (2007). Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. Erratum in: Journal of Clinical Oncology, 25(24), 3790.
Aaronson N, Elliott T, Greenhalgh J, Halyard M, Hess R, Miller D, et al. User’s guide to implementing patient-reported outcomes assessment in clinical practice [Internet], Version 2: 2015 January. Retrieved September 2, from: http://www.isoqol.org/UserFiles/2015UsersGuide-Version2.pdf.
Adjuvant chemotherapy for advanced head and neck squamous carcinoma: final report of the Head and Neck Contracts Program. Cancer. 1987;60(3):301–311.
Laramore, G. E., Scott, C. B., al-Sarraf, M., Haselow, R. E., Ervin, T. J., Wheeler, R., et al. (1992). Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on Intergroup Study 0034. International Journal of Radiation Oncology, Biology, Physics, 23(4), 705–713. CrossRefPubMed
Atkinson, T. M., Li, Y., Coffey, C. W., Sit, L., Shaw, M., Lavene, D., et al. (2012). Reliability of adverse symptom event reporting by clinicians. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 21(7), 1159–1164. CrossRef
- Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer
Joshua R. Niska
Michele Y. Halyard
Angelina D. Tan
Pamela J. Atherton
Samir H. Patel
Jeff A. Sloan
- Springer International Publishing